SA
STOCK ALARM
STOCK ALARM
SA
Menu
Demo
Log In
SPRY
(SPRY)
SPRY
Overview
Notebook
Intelligence
Chart
History
Fundmntls
TTM
Earnings
Analysts
News
Financials
Segments
Insiders
Institl.
DCF
Peers
Trailing Twelve Months (TTM) Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
Home
Screener
Alerts
Search
More
ARS Pharmaceuticals, Inc.
(SPRY)
$8.41
—
Chart
Share
Post on X
SPRY
ARS Pharmaceuticals, Inc.
(SPRY)
NASDAQ
$8.41
—
Chart Studio
Share
SPRY
Per Share (TTM)
Revenue/Share
$1.00
Net Income/Share
$-1.99
Operating CF/Share
$-1.76
Free CF/Share
$-1.77
Cash/Share
$2.02
Book Value/Share
$0.62
Tangible Book/Share
$0.47
Equity/Share
$0.62
Interest Debt/Share
$1.00
CapEx/Share
$0.00
Dividend/Share
$0.00
Valuation
Market Cap
$835.14M
Enterprise Value
$907.34M
P/E Ratio
-4.18
P/S Ratio
8.44
P/OCF Ratio
-4.77
P/FCF Ratio
-4.76
P/B Ratio
13.62
P/TB Ratio
13.62
EV/Sales
9.17
EV/EBITDA
-4.72
Graham Valuation
Graham Number
--
Graham Net-Net
$0.01
Profitability
Earnings Yield
-23.71%
FCF Yield
-20.99%
ROE
-153.61%
ROIC
-85.03%
Return on Tangible Assets
-72.41%
Dividend
Dividend Yield
0.00%
Payout Ratio
0.00%
Capital Allocation
CapEx/OCF
-0.14%
CapEx/Revenue
0.25%
CapEx/Depreciation
0.17
SBC/Revenue
24.47%
SG&A/Revenue
263.90%
R&D/Revenue
14.71%
Liquidity & Solvency
Debt/Equity
1.57
Debt/Assets
0.34
Debt/Market Cap
0.12
Net Debt/EBITDA
-0.38
Current Ratio
4.94
Interest Coverage
-82.92x
Income Quality
0.88
Efficiency
Days Sales Outstanding
109 days
Days Payables Outstanding
76 days
Days Inventory
142 days
Receivables Turnover
3.36x
Payables Turnover
4.82x
Inventory Turnover
2.57x
Capital Structure
Tangible Assets
$47.13M
Working Capital
$195.62M
Invested Capital
$212.09M
Intangibles/Assets
4.93%